P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS, INC. (REGN), sold 153,740 shares at $364.55 ($24.7M) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Open-market sale of $24.7M REGN by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 669 | $0 | 0.0% |
| 2 | $0.00 | 764 | $0 | 0.0% |
| 3 | $0.00 | 40,681 | $0 | 0.0% |
| 4 | $0.00 | 7,246 | $0 | 0.0% |
| 5 | $0.00 | 14,000 | $0 | 0.0% |
| 6 | $358.33 | 23,989 |
| $8.6M |
| 34.8% |
| 7 | $0.00 | 22,093 | $0 | 0.0% |
| 8 | $358.92 | 156 | $56K | 0.2% |
| 9 | $358.92 | 156 | $56K | 0.2% |
| 10 | $359.46 | 1,479 | $532K | 2.2% |
| 11 | $359.46 | 1,479 | $532K | 2.2% |
| 12 | $360.37 | 592 | $213K | 0.9% |
| 13 | $360.37 | 592 | $213K | 0.9% |
| 14 | $361.46 | 2,492 | $901K | 3.6% |
| 15 | $361.46 | 2,492 | $901K | 3.6% |
| 16 | $362.61 | 2,284 | $828K | 3.4% |
| 17 | $362.61 | 2,284 | $828K | 3.4% |
| 18 | $363.53 | 3,605 | $1.3M | 5.3% |
| 19 | $363.53 | 3,605 | $1.3M | 5.3% |
| 20 | $364.55 | 3,755 | $1.4M | 5.5% |
| 21 | $364.55 | 3,755 | $1.4M | 5.5% |
| 22 | $365.25 | 3,269 | $1.2M | 4.8% |
| 23 | $365.25 | 3,269 | $1.2M | 4.8% |
| 24 | $366.63 | 4,517 | $1.7M | 6.7% |
| 25 | $366.63 | 4,517 | $1.7M | 6.7% |
| Total | $160.76 avg | 153,740 | $24.7M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |